Skip to main content
Home
    • ALL Specialities ALL Specialities
    Home
    Home

    Anna M. Fine, PharmD

    Article

    Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy?

    Author:
    Anna M. Fine, PharmD

    Epoetin alfa and darbepoetin alfa are erythropoiesis-stimulating agents (ESAs), approved for the treatment of anemia (low red blood cells [RBCs])...

    • Read More

    Article

    Abuse-Deterrent Opioids: What Practitioners Need to Know

    Author:
    Brenda J. Rose, PharmD
    Anna M. Fine, PharmD

    The meaning of the term abuse-deterrent is often misunderstood to mean abuse-proof. The FDA defines abuse-deterrent properties as those...

    • Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties